A new group of recalls for a repair piece installed in some of BD’s Alaris infusion pumps joins more than a dozen others on the long list of serious recalls involving the device in the last decade.
This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. BD will pay a $175 million civil penalty to settle charges ...
FDA has given Class I status to a Carefusion recall related to the Alaris Model 8100 infusion pump. A software failure in the pump had been identified in modules running software version 9.1.18. Last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results